SCHEMBL29434800

SCHEMBL29434800

Cc1cccc(NC(=O)c2ccccc2)c1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNK3 O14649 9/20 0.87
▸ KCNK9 Q9NPC2 7/20 0.87
▸ MEN1 O00255 5/20 0.87
▸ KMT2A Q03164 5/20 0.87
▸ POLB P06746 1/20 0.87
▸ RXFP1 Q9HBX9 1/20 0.83
▸ KCNH2 Q12809 1/20 0.77
▸ RAB9A P51151 6/20 0.69
▸ SMN1; SMN2 Q16637 3/20 0.69
▸ NPC1 O15118 3/20 0.69
▸ TP53 P04637 2/20 0.69
▸ NFKB1 P19838 1/20 0.69
▸ NFKB2 Q00653 1/20 0.69
▸ RELA Q04206 1/20 0.69
▸ ALDH1A1 P00352 3/20 0.69
▸ MAPT P10636 4/20 0.67
▸ HTT P42858 2/20 0.67
▸ SIRT1 Q96EB6 1/20 0.67
▸ L3MBTL1 Q9Y468 2/20 0.65
▸ APAF1 O14727 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259468 1.00 KCNK3 (0.87) KCNK3KCNK9MEN1KMT2APOLB
SCHEMBL12922066 0.94 KCNK3 (0.77) KCNK3KCNK9MEN1KMT2APOLB
SCHEMBL4253897 0.91 KCNK3 (0.93) KCNK3KCNK9MEN1KMT2APOLB
SCHEMBL10090678 0.90 KMT2A (0.72) KCNK3KCNK9MEN1KMT2APOLB
SCHEMBL8461683 0.90 MEN1 (0.73) KCNK3KCNK9MEN1KMT2APOLB
SCHEMBL259706 0.89 MEN1 (0.77) KCNK3KCNK9MEN1KMT2APOLB
SCHEMBL259666 0.89 KCNK3 (0.87) KCNK3KCNK9MEN1KMT2APOLB
SCHEMBL30608967 0.89 KCNK3 (0.87) KCNK3KCNK9MEN1KMT2APOLB
SCHEMBL2908619 0.89 MEN1 (0.89) KCNK3KCNK9MEN1KMT2APOLB
Dimethylamine SCHEMBL9292692 0.87 MEN1 (0.69) KCNK3KCNK9MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580404-A2 SULFONAMIDE APYRASE INHIBITORS Texas Crop Science, Inc. (US) 2025-07-09 — — EP claimed
CN-118126043-B PLK4 inhibitor with high selectivity and preparation method and application thereof 沈阳药科大学 2025-01-28 — — CN claimed
WO-2024114574-A1 HIGH-SELECTIVITY PLK4 INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF 沈阳药科大学 2024-06-06 — — WO claimed
CN-118126043-A PLK4 inhibitor with high selectivity and preparation method and application thereof 沈阳药科大学 2024-06-04 — — CN claimed
EP-4140991-B1 INHIBITORS OF OPLOPHORUS LUCIFERASE-DERIVED BIOLUMINESCENT COMPLEXES PROMEGA CORP (US) 2024-05-15 — — EP claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US claimed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO claimed
CN-117466799-A Preparation method of N-substituted phthalimide compound 西北师范大学 2024-01-30 — — CN claimed
CN-118126043-B PLK4 inhibitor with high selectivity and preparation method and application thereof 沈阳药科大学 2025-01-28 — — CN disclosed
CN-117466799-B N-substituted phthalic acid diamide preparation method of imine compound 西北师范大学 2024-12-24 — — CN disclosed
CN-118420484-B Method for preparing amide compounds 四川大学 2024-08-30 — — CN disclosed
CN-118420484-A Method for preparing amide compounds 四川大学 2024-08-02 — — CN disclosed
WO-2024114574-A1 HIGH-SELECTIVITY PLK4 INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF 沈阳药科大学 2024-06-06 — — WO disclosed
CN-118126043-A PLK4 inhibitor with high selectivity and preparation method and application thereof 沈阳药科大学 2024-06-04 — — CN disclosed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed
CN-117466799-A Preparation method of N-substituted phthalimide compound 西北师范大学 2024-01-30 — — CN disclosed
CN-115304507-A Synthesis method of N-substituted aryl formamide 兰州石化职业技术大学 2022-11-08 — — CN disclosed
CN-114276270-A Synthesis method of compound with amido bond 湖北文理学院 2022-04-05 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP KCNK3 3991/4885KCNK9 3433/4885MEN1 4795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback